Scientists continue to make progress with induced pluripotent stem cells (iPSCs), which have the potential to transform medicine due to their capacity to develop into numerous types of cells that can be employed for treatment. Reprogramming somatic cells to induce iPSCs has provided great value, which can be developed into a variety of tissue types. Researchers now have the resources they need...

The global market for microfluidic products surged to $9.98 billion in 2019, with microfluidic devices accounting for $3.48 billion of this figure. A notable trend in the industry is the ongoing acquisition of microfluidic companies by larger enterprises, signaling a trajectory of accelerated growth through capital infusion.   In the industrial landscape, in vitro diagnostics (IVD) stands...

Microfluidic chips have garnered significant interest from both academic and industrial sectors since their inception. The launch of the journal "Lab on a Chip" in 2001 marked a pivotal moment, quickly establishing itself as a cornerstone publication and catalyzing further global research in microfluidic chips. In 2004, Business 2.0 magazine featured chip laboratories prominently, identifying...

Oligonucleotide synthesis is at the forefront of biotechnology, driving significant advancements in the development of next-generation therapeutics. These short DNA or RNA sequences are engineered to modulate gene expression, presenting novel solutions for treating a myriad of diseases, from genetic disorders to cancers.   Innovations in Oligonucleotide Synthesis A key breakthrough in this...

Australian researchers claimed that they have found a cure for cervical cancer in mice using gene-editing technology, which is a big breakthrough for gene therapy, and Creative Biolabs spares no effort in assisting global scientists to make greater progress. Earlier this month, scientists from Griffiths University’s Menzies Health Institute Queensland used gene editing technology...

iPSCs hold immense potential in disease modeling and drug screening, and ensuring their pluripotency and viability is crucial to realizing their application value. "Therefore, particular emphasis is placed on iPSC pluripotency characterization services," stated an expert in the field.   Validating and detecting iPSC pluripotency markers significantly benefits subsequent proliferation and...

The complement system is a critical component of the innate immune system, orchestrating a cascade of reactions to recognize and eliminate pathogens, while promoting inflammation. However, overactivation of the complement system can lead to various inflammatory and autoimmune diseases.   The complement system comprises a group of serum proteins that can be activated through three pathways:...

Alzheimer's disease (AD) is a common neurodegenerative encephalopathy which occurs in pre- and post-elderly conditions with a gradual loss of cognitive and memory functions. As the population aging intensifies, the number of AD patients worldwide is growing rapidly, resulting in a heavy social burden. Thus, how to treat Alzheimer's disease is the focus of the whole society. In fact, the...

A novel liposome product, doxorubicin hydrocholoride liposomal injection, has received FDA approval as well as European Commission authorization to be used in the treatment of a variety of cancers, including ovarian cancer, acquired immune deficiency syndrome (AIDS)-related Kaposi's sarcoma, and multiple myeloma. It is no doubt another piece of good news for...

The pursuit of improved therapeutic efficacy in medicine has propelled the development of advanced drug delivery systems. Among these innovations, liposomal formulations have emerged as a groundbreaking approach in the field of pharmacology. This technique leverages the unique properties of liposomes—spherical vesicles composed primarily of phospholipid bilayers—to enhance the...